<DOC>
	<DOC>NCT03009721</DOC>
	<brief_summary>The purpose of this study is to investigate the effectiveness and safety of Olostar Tab in patients with essential hypertension and dyslipidemia</brief_summary>
	<brief_title>Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Male or female â‰¥ 19 Patients have record of blood pressure (SBP/DBP) and LDLC after prescription of Olostar Tab. Patients that have participated clinical trials or PMS with Olostar Tab.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>